Related by context. Frequent words. (Click for all words.) 77 Regains Compliance With 76 Regains Compliance 69 Continued Listing 69 Option Grants 68 Shareholder Lawsuit 68 Annual Meeting Date 67 FY# Guidance 67 Abraxis trades 66 NASDAQ Listing 66 Q2 Loss Narrows 66 Minimum Bid Price 65 Files Annual Report 65 Extends Tender Offer 65 Provides Guidance 64 NASDAQ Listing Rule 64 Q3 Loss Narrows 64 Stock Buyback 64 Guides FY# Quick Facts 64 Issues Guidance 64 Updates Guidance 64 #.#/Share [002] 63 Share Repurchases 63 Q2 Loss Widens 63 NASDAQ Listing Rules 63 Listing Requirements 63 Q4 Loss Narrows 63 Completes Tender Offer 63 Q1 Loss Widens 63 CFO Resigns 63 Statutory Basis 63 Shelf Registration Statement 62 Staff Determination Letter 62 Delist 62 Listing Standards 62 Offering Quick Facts 62 Shareholder Vote 62 Share Buyback 62 Vertex Pharmaceuticals Announces 62 Previously Announced 62 Share Repurchase Plan 62 Late Filing 62 Commence Trading 62 Hostile Bid 62 Filing Deadline 62 Q4 Loss Widens 62 Director Shareholding 62 Q3 Loss Widens 62 ESIO 61 Nasdaq Listing Rule 61 Stockholders Approve Merger 61 Succession Plan 61 Stock Repurchase Plan 61 Announces Share Repurchase 61 Complies 61 Cash Tender Offers 61 #.#X ABOVE AVERAGE VOLUME 61 RELEASES ITS QUARTERLY NUMBERS 61 Extends Offer 61 Shareholder Approval 60 Preliminary Fourth Quarter 60 Dividend Payment 60 symbol ACTU 60 Activity Alert 60 Stockholders Approve 60 Commences Trading 60 Trading Halt 60 Upcoming Investor Conference 60 Posts Wider Loss 60 Complete Merger 60 Symbol Change 60 SMARTREND DETECTS CONTINUED SELLING 59 DEALINGS BY PERSONS WITH 59 Preliminary Third Quarter 59 Fourth Consecutive Year 59 Receives Notice 59 Compl 59 Non Compliance 59 Salix trades 59 SMARTREND RESEARCH REPORT AVAILABLE 59 CEO Exercises Options 59 Shares Soar 59 Proposed Rule Change 59 M d yyyy 59 Provides Preliminary 58 Webcast Annual Meeting 58 ticker symbol LAVA 58 Patent Infringement Lawsuit 58 Announces Shareholder Approval 58 Final Approval 58 ICXT 58 SECURITIES AND EXCHANGE COMMISSION 58 FDA Accepts 58 Nasdaq SmallCap 58 Provides Updates 58 2nd Quarter Results 58 EpiCept Corporation 58 Shareholder Letter 58 Fibrocell Science Inc. 58 Begin Trading 58 3rd Quarter Results 58 ticker symbol SLXP